ALK and chronic myelogenous leukemia, BCR-ABL1 positive: We further explored long read based fusion transcript detection using transcriptomes from nine cancer cell lines derived from diverse cancer types including breast cancer (SKBR3, HCC1187, HCC1395), prostate cancer (VCaP), chronic myelogenous leukemia (K562), ALK+ anaplastic large cell lymphoma (KIJK), T cell lymphoma (MJ), small cell lung cancer (DMS53), and urothelial bladder cancer (RT112).